With the arrival of Semaglutide Generics India 2026 , several leading pharmaceutical companiesincluding Sun Pharma, Zydus Lifesciences, Dr
Its an unbelievable potential benefit because so many severe diseases [like cardiovascular disease, liver disease and chronic kidney disease] are associated with diabetes, says Dr
These findings pertain exclusively to Eli Lilly's investigational pharmaceutical program and carry no implication of approval or therapeutic suitability for Novera Compounds' independently manufactured research reagent
On the other hand, certain studies have demonstrated the overexpression of GLP-1R in brain tumors, embryonic tumors, gut and lung neuroendocrine tumors, including other endocrine tumors like Pheochromocytomas, raising concerns that existing GLP-1RAs can contribute to tumor growth in humans ( Statements Data availability statement The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author
Currently, the effects of 2.4 mg semaglutide once weekly are being explored in 1200 participants with biopsy-confirmed NASH in a Phase III clinical trial with a combined primary endpoint of resolution of NASH without worsening fibrosis, improvement in liver fibrosis without worsening of steatohepatitis, and time to first liver-related clinical event (NCT04822181) (see Table 2)